Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

UV Imaging Accessory

By Drug Discovery Trends Editor | February 12, 2010

Synbiosis, a world-leading manufacturer of automated microbiological systems, has introduced ProcUV, a UV imaging accessory for the ProtoCOL 2 system. ProcUV permits instant imaging of fluorescent colonies and plaques so they can be automatically counted or analyzed by ProtoCOL 2, thus saving time and improving accuracy of results.

Based on advanced fluorescent imaging technology, the compact ProcUV accessory, which can be simply connected to the ProtoCOL 2 system, consists of a cabinet with a sliding, auto-locking door to prevent accidental UV exposure. The cabinet contains a high resolution camera and internal UV and white lighting and is also equipped with specialized interchangeable filters, to allow microbiologists to view fluorescing bacteria, such as Pseudomonas fluorescens, fluorescent plaques and bacteria expressing Green Fluorescent Proteins.

ProcUV is simple to set up as its automatic exposure time settings ensure users can capture colony images at the touch of a button. The high-quality images can then be directly transferred into the ProtoCOL 2 in seconds, where the ProtoCOL 2 counts and analyzes results automatically, to save microbiologists countless hours of repetitive work.

Fluorescent colonies and plaques are the most difficult ones to count, as they require specific UV lighting conditions to be able to see them. This means that a powerful imaging system equipped with specialized filters to enable the camera to image each fluorescing colony is required.

Synbiosis


Filed Under: Drug Discovery

 

Related Articles Read More >

New gonorrhea antibiotic could treat resistant infections
In door grow hemp. Cannabis at the beginning of flowering. Legal Marijuana cultivation in the home. Green background of leaves. Young cannabis plant. Medicinal indica with CBD.
Why Schedule III cannabis could be a win for Big Pharma
Red blood cells macro over red eritrosit background. Concept of blood cells count, medicine and healthcare. 3d rendering mock up
Platelet-inspired nanoparticle delivers drugs directly where they are needed
Lilly’s triple agonist delivers up to 71.2 lbs of weight loss in Phase 3 trial
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE